I n this issue of the journal Daniel Reidpath and Pascale Allotey provocatively wonder if disability adjusted life expectancy (DALE) brings more information than infant mortality rate (IMR) when comparing the overall health status of different populations. 1 It is a relevant question because on the one hand IMR is easy to compute and to understand. It requires mortality and population data, which are not too difficult to collect. On the other hand DALE is quite difficult to compute and to precisely understand. It requires a lot of data that are much more difficult and expensive to collect thus raising additional data quality concerns.
When the WHO published for the first time an estimation of DALE for the its 191 member states for the years 1997 and 1999, 2 Secondly, taking into account limited data availability in most countries, are not the data, mainly estimated from or adjusted to mortality, manufacturing DALE similar to LE? If DALE/HALE hardly brings more information than LE, it is much easier to focus on mortality data still deficient in many developing countries. And, as IMR is a very good proxy for LE, it is much better to focus on mortality data during the first year of life to improve the quality of the population health indicators used.
Moreover, WHO still needs to demonstrate that its DALE/HALE summarises properly the different health dimensions and level of severity in countries with high data quality and well established chronological series such as England and Wales where it is possible to monitor a redistribution of the disability severity level. 10 In the most developed countries, the main interest yields on active life expectancy (ALE) or DFLE, recommended by the G7 11 and newly established as structural indicator by the European Union, because what is important when LE as well as the proportion of old and oldest-old people is high is to know how long people can live without difficulty in activities of daily life (ADL or IADL type) and how long they can live independently without the need of someone's help for daily living.
Thus if for the less developed countries, the "here and now" reactivity of the IMR is particularly relevant, for the most developed countries contrasting ALE or DFLE to LE is essential. In this context, DALE/HALE intends to permit comparison between all the countries. The point is to know whether it is relevant to use, as population summary health indicator for comparing all the counties, an indicator that is poorly relevant for both for the less and the most developed countries.
